Author

Munazza Samar Khan

The University of Texas MD Anderson Cancer CenterORCID 0000-0001-7447-8769Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

Hui‐Wen LoiD· 2 shared Ankush ChandraiD· 1 shared Antonio DonoiD· 1 shared Austin ArrigoiD· 1 shared Chuling ZhuangiD· 1 shared Dongqin ZhuiD· 1 shared Grace L. Wong· 1 shared Jay‐Jiguang ZhuiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Hui‐Wen LoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintJun 5, 2025

Extracellular vesicle-derived miR-425-5p (miR-425) activates astrocytes in the brain to promote breast cancer brain metastasis via the novel miR-425-ZNF24-CCL8 signaling axis

Grace L. Wong, Munazza Samar Khan, Sara G. Manore…·Hui‐Wen Lo

This study identifies miR-425 in breast cancer extracellular vesicles as a driver of brain metastasis by activating astrocytes through the miR-425-ZNF24-CCL8 signaling axis.

DOI 10.1101/2025.06.05.658130

mouseexperimental assay

Cancer BiologybioRxivPreprintFeb 20, 2025

Targeting tGLI1, a novel mediator of tumor therapeutic resistance, using Ketoconazole sensitizes glioblastoma to CDK4/6 therapy and Chemoradiation

Yu Pu Yang, Austin Arrigo, Ankush Chandra…·Hui‐Wen Lo

This paper identifies tGLI1 as a mediator of GBM resistance to CDK4/6 inhibitors and shows that ketoconazole sensitizes GBM to CDK4/6 therapy and chemoradiation.

1 citation

humanbulk RNA-seq